Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-25-045737

President and CEO sold 21,000 shares at $19.79 ($415,590)

  • President and CEO acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Grossman Adam S · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-15 Exercise or conversion : show line 1 in the form 10b5-1 +15,000 $5.40 $81,000 2,028,850 D
2025-12-15 Sale : show line 2 in the form 10b5-1 −15,000 $19.79 $296,850 2,013,850 D
2025-12-15 Sale : show line 3 in the form 10b5-1 −6,000 $19.79 $118,740 2,007,850 D
Open-market sales · 21,000 sh · avg $19.79 · $415,590

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-15 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −15,000 720,950 D
Loading xslF345X05/form4.xml…